Sponsored
Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26
Posted
India's pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across various regions. The hospital segment is expected to lead with a 17% growth, while diagnostics firms anticipate a 14% sales increase. Government initiatives and investments in R&D further support the industry's optimistic outlook.
Search
Categories
- National
- International
- Business
- Technology
- Health
- Education
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
NPS vs UPS: Big move for central government employees! NPS tax benefits now available under UPS - here’s what it means
To boost the Unified Pension Scheme (UPS), the Finance Ministry has extended National Pension...
PM Oli meets Swiss Foreign Minister
KATHMANDU: Prime Minister KP Sharma Oli held a courtesy meeting today with Swiss Federal...
President appoints three Justices to Supreme Court
KATHMANDU: President Ram Chandra Paudel has appointed three new justices to the Supreme...